Attached files
| file | filename |
|---|---|
| EX-31.1 - EX-31.1 - VALEANT PHARMACEUTICALS INTERNATIONAL | a55268exv31w1.htm |
| EX-31.2 - EX-31.2 - VALEANT PHARMACEUTICALS INTERNATIONAL | a55268exv31w2.htm |
| EX-3.3 - EX-3.3 - VALEANT PHARMACEUTICALS INTERNATIONAL | a55268exv3w3.htm |
| EX-32 - EX-32 - VALEANT PHARMACEUTICALS INTERNATIONAL | a55268exv32.htm |
| EX-21 - EX-21 - VALEANT PHARMACEUTICALS INTERNATIONAL | a55268exv21.htm |
| 10-K - FORM 10-K - VALEANT PHARMACEUTICALS INTERNATIONAL | a55268e10vk.htm |
Exhibit 23
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3
(File No. 333-112904) and Form S-8 (File Nos. 33-56971, 333-81383, 333-73098, 333-85572,
333-109877, 333-109879, 333-142651, 333-156931 and 333-160393) of Valeant Pharmaceuticals
International of our report dated February 23, 2010 relating to the financial statements, financial
statement schedule and the effectiveness of internal control over financial reporting, which
appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP
Orange County, California
February 23, 2010
Orange County, California
February 23, 2010